Skip to main content
OpenTrials

Clinical trial condition

Moderate to Severe Glabellar Lines

Explore clinical trials studying Moderate to Severe Glabellar Lines. Study availability and eligibility vary by location and protocol.

13 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Moderate to Severe Glabellar Lines trial results

Recruiting

A Study to Assess the Effectiveness and Safety of IPN10200 in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

NCT07427797

Conditions
Moderate to Severe Glabellar Lines
Locations
  • Skin Wellness Dermatology - Homewood Birmingham, Alabama, United States
  • Advanced Research Associates Glendale, Arizona, United States
  • Avacare Scottsdale, Arizona, United States
  • Investigate MD, LLC Scottsdale, Arizona, United States
View all 23 locations
View Trial Details
Recruiting

A Study to Assess the Effectiveness and Safety of IPN10200 Over Time in Adults With Moderate to Severe Wrinkle-like Lines Between the Eyebrows

NCT07435428

Conditions
Moderate to Severe Glabellar Lines
Locations
  • Rivkin Westside Aesthetics Los Angeles, California, United States
  • Clinical Testing of Beverly Hills Los Angeles, California, United States
  • Eye Research Foundation Newport Beach, California, United States
  • Steve Yoelin MD Medical Associates Inc Newport Beach, California, United States
View all 60 locations
View Trial Details
Recruiting

Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar Lines

NCT06937944

Conditions
Moderate to Severe Glabellar Lines
Locations
  • Peking Union Medical College Hospital Beijing, Beijing Municipality, China
  • Peking University First Hospital Beijing, Beijing Municipality, China
  • Peking University Third Hospital Beijing, Beijing Municipality, China
  • The First Affiliated Hospital of Chongqing Medical University Chongqing, Chongqing Municipality, China
View all 15 locations
View Trial Details
Completed

A Study on the Efficacy and Safety of Repeated Treatments With Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

NCT06583486

Conditions
Moderate to Severe Glabellar Lines
Locations
  • Guangdong Second People's Hospital Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 16 locations
View Trial Details
Completed

A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar Lines

NCT06499688

Conditions
Moderate to Severe Glabellar Lines
Locations
  • Guangdong Second People's Hospital Guangzhou, Guangdong, China
  • Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
  • The Third Affiliated Hospital of Sun Yat-sen University Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 16 locations
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines

NCT05463965

Conditions
Moderate to Severe Glabellar Lines
Locations
  • Guangdong Second Provincial General Hospital Guangzhou, Guangdong, China
  • Xiangya 3rd Hospital Changsha, Hunan, China
  • Zhejiang Provincial People's Hospital Hangzhou, Zhejiang, China
  • Beijing Tongren Hospital, CMU Beijing, China
View Trial Details